
New psychedelic clinics treat rare post-trip harms
As psychedelic therapies expand, new clinics treat uncommon long-term harms

New psychedelic clinics treat rare post-trip harms
As psychedelic therapies expand, new clinics treat uncommon long-term harms

Why loneliness and not social isolation may be making you sick
One in six people are thought to experience loneliness, and that can have a serious knock-on effect on their mental and physical health


Could psilocybin be the key to treating anorexia?
An active ingredient in magic mushrooms, psilocybin has shown early promise for treating eating disorders

What to know about postpartum psychosis
A high-profile court case is calling attention to this rare and understudied condition

1 in 3 psychologists say their patients use AI as a second therapist. Here’s what they want you to know
People are increasingly turning to AI for mental health support—but its design is “antithetical” to mental health care, experts say

Could the keto diet help treat anorexia, schizophrenia and depression?
Early research suggests that some mental health conditions could stem from metabolic disorders. If so, the findings could change how we treat mental illness

Remote work is making Americans lonelier and sadder, new study suggests
Remote and hybrid work can have benefits, but a study involving more than 588,000 people suggest they may take a serious mental toll

An Olympian scientist explains why online fitness content can be dangerous
The Internet loves fitness-motivation content. Olympian and researcher Valerie Gruest explains why it can be so harmful

Should schools limit kids’ screen time? The science is murky
Los Angeles public schools are limiting computer use in classrooms over health concerns. But experts say that approach is missing the problem

RFK, Jr., says ibogaine holds unprecedented promise for treating depression. Here’s what the science says
At a Senate hearing on Wednesday, Robert F. Kennedy, Jr., referred to ibogaine as the most promising treatment for PTSD and depression “that anybody’s ever seen.” Does the science hold that up?

RFK, Jr., puts psychedelics on fast track to FDA review and approval
The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying psilocybin and an MDMA-like drug as treatments for depression and PTSD

Young adult suicide rates dropped after U.S. launched 988 hotline
The states with the greatest increases in 988 crisis hotline use since 2022 experienced the greatest decrease in suicide mortality, but the hotline alone may not explain the drop